Exhibit 10.27
CONSENT TO ALTERATIONS AGREEMENT
THIS AGREEMENT MADE EFFECTIVE AS OF AUGUST 16, 2023
BETWEEN
REDSTONE ENTERPRISES LTD.
(“Landlord”)
AND
XENON PHARMACEUTICALS INC.
(“Tenant”)
WHEREAS
THEREFORE, the parties hereby agree as follows:
1
For clarity, the costs associated with the above shall not be included in the maximum amount specified in Section 32.0 RESTORATION of the Original Lease.
2
IN WITNESS WHEREOF the parties have executed this Agreement as of the date first above written.
REDSTONE ENTERPRISES LTD. (Landlord)
By: /s/ Ali Nanji
Name: Ali Nanji
Title: President
By: /s/ Brodie Cain
Name: Brodie Cain
Title: Director of Leasing
XENON PHARMACEUTICALS INC. (Tenant)
By: /s/ Sherry Aulin
Authorised Signatory for and on behalf of
Xenon Pharmaceuticals Inc.
Name: Sherry Aulin
Title: Chief Financial Officer
By: /s/ Andrea DiFabio
Authorised Signatory for and on behalf of
Xenon Pharmaceuticals Inc.
Name: Andrea DiFabio
Title: Chief Legal Officer
3